[Essential hypercholesteremic xanthomatosis (Frederickson's hyperlipoproteinemia type IIb)].
[Case of type IV hyperlipoproteinemia (Frederickson's classification)].
[Influence of fat or carbohydrate rich diet on the serum lipoprotein pattern of a child with primary hypertriglyceridemia (type V hyperlipoproteinemia according to Frederickson) (author's transl)].
Cost-effectiveness study of a lipid-lowering therapy in hyperlipoproteinaemia type IIb and type IV (Frederickson).
Bergemann R, Brandt A, Siegrist W.
Pharmacoeconomics. 1993 Feb;3(2):131-9. doi: 10.2165/00019053-199303020-00006.
[Influence of fat or carbohydrate rich diet on the serum lipoprotein pattern of a child with primary hypertriglyceridemia (type V hyperlipoproteinemia according to Frederickson) (author's transl)].
Müller WD, Kostner GM.
Wien Klin Wochenschr. 1974 Dec 27;86(24):757-62.
Acute tendinitis and arthritis. A presenting symptom of familial type II hyperlipoproteinemia.
Glueck CJ, Levy RI, Frederickson DS.
JAMA. 1968 Dec 23;206(13):2895-7. doi: 10.1001/jama.206.13.2895.
[Case of type IV hyperlipoproteinemia (Frederickson's classification)].
Kwiatkowski S, Smolik R, Szechiński J.
Wiad Lek. 1972 Sep 1;25(17):1591-4.
[Essential hypercholesteremic xanthomatosis (Frederickson's hyperlipoproteinemia type IIb)].
Schink W.
Handchirurgie. 1976;8(1):37.
Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with Frederickson type IV dyslipidemia phenotype.
Bermúdez-Pirela V, Souki A, Cano-Ponce C, Bermúdez-Arias F, Mengual-Moreno E, Leal-Gonzalez E, Lemus-Antepaz M, de Bravo MC, de Díaz AA, de Pirela NL, Cano-Peñaloza R, Puche-Medina G, Arraiz N, Reyna-Villazmil N, Contreras F, Israili ZH, Valasco M.
Am J Ther. 2007 Mar-Apr;14(2):213-20. doi: 10.1097/01.pap.0000249920.70815.2d.
Familial hyperlipidemia in stroke in the young.
Bansal BC, Sood AK, Bansal CB.
Stroke. 1986 Nov-Dec;17(6):1142-5. doi: 10.1161/01.str.17.6.1142.
Cost effectiveness of micronised fenofibrate and simvastatin in the short-term treatment of type IIa and type IIb hyperlipidaemia.
Kirchgässler KU, Schiffner-Rohe J, Stahlheber U.
Pharmacoeconomics. 1997 Aug;12(2 Pt 2):237-46. doi: 10.2165/00019053-199712020-00014.
Primary hyperlipoproteinemia in xanthomatosis.
Hessel LW, Vermeer BJ, Polano MK, De Jonge H, De Pagter HA, Van Gent CM.
Clin Chim Acta. 1976 Jun 15;69(3):405-16. doi: 10.1016/0009-8981(76)90112-1.
Studies of triacyglycerol structure of very low density lipoproteins of normolipemic subjects and patients with type III and type IV hyperlipoproteinemia.
Myher JJ, Kuksis A, Breckenridge WC, Little JA.
Lipids. 1984 Sep;19(9):683-91. doi: 10.1007/BF02534528.
